F.P. Vleggaar

489 total citations
13 papers, 157 citations indexed

About

F.P. Vleggaar is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, F.P. Vleggaar has authored 13 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Hepatology and 4 papers in Oncology. Recurrent topics in F.P. Vleggaar's work include Esophageal and GI Pathology (4 papers), Inflammatory Bowel Disease (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). F.P. Vleggaar is often cited by papers focused on Esophageal and GI Pathology (4 papers), Inflammatory Bowel Disease (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). F.P. Vleggaar collaborates with scholars based in Netherlands, Italy and Germany. F.P. Vleggaar's co-authors include Türkan Terkivatan, Henk R. van Buuren, Marjolaine Willems, K Linde, Peter Siersema, E. Totté, Meike M. Hirdes, Peter D. Siersema, Marian M. Claessen and Jan F. Monkelbaan and has published in prestigious journals such as Journal of Hepatology, Radiotherapy and Oncology and Endoscopy.

In The Last Decade

F.P. Vleggaar

13 papers receiving 154 citations

Peers

F.P. Vleggaar
Ahmad Al‐Rifai United Kingdom
Arnaud Monier Switzerland
Ibrahim Altraif Saudi Arabia
Milton R. Hales United States
F.P. Vleggaar
Citations per year, relative to F.P. Vleggaar F.P. Vleggaar (= 1×) peers P.H.G.M. Stadhouders

Countries citing papers authored by F.P. Vleggaar

Since Specialization
Citations

This map shows the geographic impact of F.P. Vleggaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.P. Vleggaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.P. Vleggaar more than expected).

Fields of papers citing papers by F.P. Vleggaar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.P. Vleggaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.P. Vleggaar. The network helps show where F.P. Vleggaar may publish in the future.

Co-authorship network of co-authors of F.P. Vleggaar

This figure shows the co-authorship network connecting the top 25 collaborators of F.P. Vleggaar. A scholar is included among the top collaborators of F.P. Vleggaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.P. Vleggaar. F.P. Vleggaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Moons, Leon M.G., et al.. (2020). PATENCY OF EUS-GUIDED GASTROENTEROSTOMY IN THE TREATMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION. Endoscopy. 1 indexed citations
2.
Heerkens, H.D., Marco van Vulpen, O. Reerink, et al.. (2014). EP-1262: MRI-guided SBRT with individualised margins for locally advanced pancreatic cancer ñ a feasibility and safety study. Radiotherapy and Oncology. 111. S75–S76. 1 indexed citations
3.
Cieslak, Kasia P., Hjalmar C. van Santvoort, F.P. Vleggaar, et al.. (2013). The role of preoperative EUS in addition to CT in patients suspected of pancreatic or periampullary cancer. Pancreatology. 13(2). e21–e21. 1 indexed citations
4.
Cieslak, Kasia P., F.P. Vleggaar, Maarten S. van Leeuwen, et al.. (2012). The role of preoperative EUS in addition to CT in patients suspected of pancreatic or periampullary cancer. Pancreatology. 12(6). 564–564. 1 indexed citations
5.
Schrijver, A. Marjolein, Peter D. Siersema, F.P. Vleggaar, Meike M. Hirdes, & Jan F. Monkelbaan. (2011). Endoclips for fixation of nasoenteral feeding tubes: A review. Digestive and Liver Disease. 43(10). 757–761. 4 indexed citations
6.
Claessen, Marian M., Peter D. Siersema, & F.P. Vleggaar. (2011). IBD-related carcinoma and lymphoma. Best Practice & Research Clinical Gastroenterology. 25. S27–S38. 6 indexed citations
7.
Hirdes, Meike M., F.P. Vleggaar, K Linde, et al.. (2010). Esophageal perforation due to removal of partially covered self-expanding metal stents placed for a benign perforation or leak. Endoscopy. 43(2). 156–159. 46 indexed citations
8.
Vleggaar, F.P., Maurice Lutgens, Bas Oldenburg, M.E.I. Schipper, & Melvin Samsom. (2007). [British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease].. PubMed. 151(50). 2787–91. 5 indexed citations
10.
Buuren, Henk R. van, et al.. (2000). High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitisNote. Journal of Hepatology. 33(4). 543–548. 88 indexed citations
11.
Vleggaar, F.P., Bettina E. Hansen, G. P. van Berge Henegouwen, & Henk R. van Buuren. (2000). The incidence and prognostic significance of major clinical events in primary sclerosing cholangitis. Journal of Hepatology. 32. 128–128. 1 indexed citations
12.
Vleggaar, F.P., Henk R. van Buuren, G. P. van Berge Henegouwen, Wim C.J. Hop, & Karel J. van Erpecum. (2000). No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: Results of a randomized placebo-controlled cross-over study. Journal of Hepatology. 32. 131–131. 1 indexed citations
13.
Buuren, Henk R. van, Michael Groeneweg, F.P. Vleggaar, et al.. (2000). The results of a randomized controlled trial evaluating tips andendoscopic therapy in cirrhotic patients with gastro-esophagealvariceal bleeding. Journal of Hepatology. 32. 71–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026